natgillin/translations-raw huggingface dataset:
Some patients have experienced a heart attack, stroke or “mini-stroke” while receiving pemetrexed usually in combination with another anticancer therapy
neki su bolesnici doživjeli srčani udar, moždani udar ili „mali moždani udar“ pri primjeni lijeka pemetreksed, obično u kombinaciji s nekim drugim protutumorskim lijekom
Some patients have experienced a heart attack, stroke or “mini-stroke” while receiving pemetrexed usually in combination with another anticancer therapy.
Neki su bolesnici doživjeli srčani udar, moždani udar ili „mali moždani udar“ pri primjeni pemetrekseda, obično u kombinaciji s nekim drugim protutumorskim lijekom
Some patients have experienced allergic reactions (frequency rare), which may be serious, including wheezing and shortness of breath (bronchial hyperreactivity; frequency uncommon).
Neki bolesnici su imali alergijske reakcije (učestalost rijetka) koje mogu biti teške, uključujući piskanje u plućima i kratkoću daha (bronhalna hiperreaktivnost; učestalost manje česta).
Some patients have experienced allergic reactions (hypersensitivity; frequency not known while taking Trajenta alone, frequency cannot be estimated from the available data), which may be serious, including wheezing and shortness of breath (bronchial hyperreactivity; frequency not known while taking Trajenta alone).
Neki bolesnici su imali alergijske reakcije (preosjetljivost; učestalost nije poznata u razdoblju primjene monoterapije Trajentom, učestalost se ne može procijeniti iz dostupnih podataka), koje mogu biti ozbiljne, uključujući piskanje i nedostatak zraka (hiperreaktivnost bronha; učestalost nije poznata u razdoblju primjene monoterapije Trajentom).
Some patients have experienced changes in skin colour in the area where Zyclara was applied.
Neki bolesnici su iskusili promjene boje kože u području na kojem je bila primjenjivana Zyclara.
Some patients have experienced diarrhoea, nausea, flatulence, constipation, stomach ache or vomiting when starting the combination of sitagliptin and metformin together (frequency is common)..
Pri istodobnom uzimanju kombinacije sitagliptina i metformina neki su bolesnici na početku liječenja imali proljev, mučninu, vjetrove, zatvor, bol u trbuhu ili su povraćali (učestalost je česta).
Some patients have experienced inflammation of the pancreas (pancreatitis; frequency not known while taking Trajenta alone).
Neki bolesnici su imali upalu gušterače (pankreatitis, učestalost nije poznata u razdoblju primjene monoterapije Trajentom).
Some patients have experienced inflammation of the pancreas (pancreatitis; frequency not known, frequency cannot be estimated from the available data).
Neki bolesnici su imali upalu gušterače (pankreatitis, učestalost nije poznata, ne može se utvrditi iz dostupnih podataka).
Some patients have experienced severe back cramps or pain which lead to hospitalisation.
U nekih su se bolesnika pojavili jaki grčevi ili bolovi u leđima, koje je trebalo liječiti u bolnici
Some patients have experienced the following serious side effects whilst taking fenofibrate or simvastatin (both active substances in Cholib): allergic reaction - the signs may include swelling of the face, lips, tongue or throat, which may cause difficulty in breathing
Neki su bolesnici imali sljedeće ozbiljne nuspojave dok su uzimali fenofibrat ili simvastatin (obje djelatne tvari u Cholibu):
Some patients have experienced the following side effects during clinical studies while taking sitagliptin alone (one of the medicines in Efficib) or during post-approval use of Efficib or sitagliptin alone or with other diabetes medicines:
Neki bolesnici koji su u kliničkim ispitivanjima uzimali samo sitagliptin (jednu od djelatnih tvari lijeka Janumet), kao i bolesnici koji su koristili Janumet ili sitagliptin, nakon njihova stavljanja u promet, same ili s drugim lijekovima za šećernu bolest, imali su sljedeće nuspojave:
Some patients have experienced the following side effects during clinical studies while taking sitagliptin alone (one of the medicines in Janumet) or during post-approval use of Janumet or sitagliptin alone or with other diabetes medicines:
Neki bolesnici koji su u kliničkim ispitivanjima uzimali samo sitagliptin (jednu od djelatnih tvari lijeka Janumet), kao i bolesnici koji su koristili Janumet ili sitagliptin, nakon njihova stavljanja u promet, same ili s drugim lijekovima za šećernu bolest, imali su sljedeće nuspojave:
Some patients have experienced the following side effects during clinical studies while taking sitagliptin alone (one of the medicines in Ristfor) or during post-approval use of Ristfor or sitagliptin alone or with other diabetes medicines:
Neki bolesnici koji su u kliničkim ispitivanjima uzimali samo sitagliptin (jednu od djelatnih tvari lijeka Janumet), kao i bolesnici koji su koristili Janumet ili sitagliptin, nakon njihova stavljanja u promet, same ili s drugim lijekovima za šećernu bolest, imali su sljedeće nuspojave:
Some patients have experienced the following side effects during clinical studies while taking sitagliptin alone (one of the medicines in Velmetia) or during post-approval use of Velmetia or sitagliptin alone or with other diabetes medicines:
Neki bolesnici koji su u kliničkim ispitivanjima uzimali samo sitagliptin (jednu od djelatnih tvari lijeka Janumet), kao i bolesnici koji su koristili Janumet ili sitagliptin, nakon njihova stavljanja u promet, same ili s drugim lijekovima za šećernu bolest, imali su sljedeće nuspojave:
Some patients have experienced the following side effects while taking Eucreas:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Eucreas:
Some patients have experienced the following side effects while taking Icandra:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Icandru:
Some patients have experienced the following side effects while taking Jentadueto with insulin
Neki bolesnici su imali sljedeće nuspojave tijekom uzimanja Jentadueta s inzulinom
Some patients have experienced the following side effects while taking metformin alone:
Neki bolesnici koji su uzimali samo metformin imali su sljedeće nuspojave:
Some patients have experienced the following side effects while taking sitagliptin alone in clinical studies, or during post-approval use alone and/or with other diabetes medicines:
U nekih bolesnika koji su u kliničkim ispitivanjima uzimali sitagliptin sam, odnosno nakon stavljanja lijeka u promet sitagliptin sam i/ili zajedno s drugim lijekovima za liječenje šećerne bolesti, javile su se sljedeće nuspojave:
Some patients have experienced the following side effects while taking sitagliptin in combination with a sulphonylurea and metformin:
Pri uzimanju sitagliptina u kombinaciji sa sulfonilurejom i metforminom u nekih su bolesnika nastupile sljedeće nuspojave:
Some patients have experienced the following side effects while taking Zomarist:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Zomarist:
Some patients have had blood tests or symptoms indicating that their hepatitis has got worse after stopping emtricitabine or tenofovir disoproxil fumarate (two of the three active substances of Eviplera).
Neki su pacijenti imali krvne nalaze ili simptome koji su pokazivali da im se hepatitis pogoršao nakon prestanka uzimanja emtricitabina ili tenofovirdizoproksilfumarata (dvije od tri djelatne tvari Eviplere).
Some patients have had blood tests or symptoms indicating that their hepatitis has got worse after stopping emtricitabine or tenofovir disoproxil fumarate (two of the three components of Atripla).
U nekih su bolesnika krvne pretrage ili simptomi ukazivali da se stanje hepatitisa pogoršalo nakon prestanka uzimanja emtricitabina ili tenofovirdizoproksilfumarata (dva od tri sastojka Atriple).
Some patients have had blood tests or symptoms indicating that their hepatitis has got worse after stopping Viread.
Neki su pacijenti imali krvne pretrage ili simptome koji su ukazivali na to da im se hepatitis pogoršao nakon prestanka liječenja Vireadom.
Some patients have had the following side effects while taking Galvus, metformin and a sulphonylurea:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Galvus, metformin i sulfonilureju:
Some patients have had the following side effects while taking Jalra and a glitazone:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Jalru i glitazon:
Some patients have had the following side effects while taking Jalra and a sulphonylurea:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Jalru i sulfonilureju:
Some patients have had the following side effects while taking Jalra and metformin:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Jalru i metformin:
Some patients have had the following side effects while taking Jalra, metformin and a sulphonylurea:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Jalru, metformin i sulfonilureju:
Some patients have had the following side effects while taking Jentadueto:
Neki su bolesnici imali sljedeće nuspojave tijekom uzimanja Jentadueta:
Some patients have had the following side effects while taking Trajenta alone:
Pojedini bolesnici su imali sljedeće nuspojave u razdoblju primjene monoterapije Trajentom:
Some patients have had the following side effects while taking Trajenta and insulin:
Pojedini bolesnici imali su sljedeće nuspojave u razdoblju primjene Trajente i inzulina:
Some patients have had the following side effects while taking Trajenta and metformin:
Pojedini bolesnici su imali sljedeće nuspojave u razdoblju primjene Trajente i metformina:
Some patients have had the following side effects while taking Trajenta, metformin and a sulphonylurea:
Pojedini bolesnici su imali sljedeće nuspojave u razdoblju primjene Trajente, metformina i sulfonilureje:
Some patients have had the following side effects while taking Xiliarx alone:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali samo Xiliarx:
Some patients have had the following side effects while taking Xiliarx and a glitazone:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx i glitazon:
Some patients have had the following side effects while taking Xiliarx and a sulphonylurea:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx i sulfonilureju:
Some patients have had the following side effects while taking Xiliarx and metformin:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx i metformin:
Some patients have had the following side effects while taking Xiliarx, metformin and a sulphonylurea:
Neki su bolesnici imali sljedeće nuspojave kada su uzimali Xiliarx, metformin i sulfonilureju:
Some patients may also experience:
Neki pacijenti također mogu razviti:
Some patients may develop antibodies (made by your body to fight a foreign protein) against the collagen in the medicine.
Neki bolesnici mogu razviti protutijela (koje proizvodi vaše tijelo za borbu protiv stranih proteina) protiv kolagena u lijeku.
Some patients may develop antibodies (made by your body to fight a foreign protein) to InductOs.
Neki bolesnici mogu razviti protutijela (koja stvara Vaše tijelo za borbu protiv stranih proteina) na InductOs.
Some patients may develop antibodies to INCRELEX.
Kod nekih bolesnika mogu se razviti antitijela na INCRELEX.
Some patients may develop factor VIII inhibitors, which are antibodies (proteins) that the body’s immune system produces against factor VIII and which can cause the medicine to stop working resulting in a loss of bleeding control.
Pojedini bolesnici mogu razviti inhibitore faktora VIII, koji su protutijela (proteini) koje imunosni sustav tijela stvara protiv faktora VIII i koji mogu uzrokovati prestanak djelovanja lijeka što može rezultirati gubitkom kontrole nad krvarenjem.
Some patients may develop nerve pain due to localised fluid collection, which would require drainage or a surgical procedure to remove the fluid.
Neki bolesnici mogu razviti bol u živcu zbog lokaliziranog nakupljanja tekućine koja bi mogla zahtijevati drenažu ili kirurški zahvat za uklanjanje tekućine.
Some patients may experience a mild sweet or slightly bitter taste, depending on the patient, when inhaling the medicinal product.
Neki bolesnici pri inhalaciji lijeka mogu osjetiti umjereno sladak ili blago gorak okus, ovisno o bolesniku.
Some patients may experience serious side effects and may require treatment.
U nekih bolesnika nuspojave mogu biti teške i zahtijevati liječenje.
Some patients may get increased levels of liver enzymes in their blood during treatment with Thymanax.
Kod nekih bolesnika može se povećati razina jetrenih enzima u krvi tijekom liječenja s lijekom Thymanax.
Some patients may get increased levels of liver enzymes in their blood during treatment with Valdoxan.
Kod nekih bolesnika može se povećati razina jetrenih enzima u krvi tijekom liječenja s lijekom Valdoxan.
Some patients may have 200 micrograms in the morning and in the evening as their maintenance dose, while some will reach the highest dose of
Neki bolesnici mogu imati dozu od 200 mikrograma ujutro i navečer kao svoju dozu održavanja, dok će neki dosegnuti najveću dozu od 1600 mikrograma ujutro i navečer.
Some patients may have been exposed to immunosuppressive medicinal products (e.g. mitoxantrone, cyclophosphamide, azathioprine).
Neki bolesnici su možda prethodno primali imunosupresive (npr. mitoksantron, ciklofosfamid, azatioprin).
Some patients may have serious side effects that may need urgent treatment.
Neki bolesnici mogu imati ozbiljne nuspojave koje možda treba hitno liječiti.
Some patients may hear a soft click right before the second loud click.
Neki bolesnici mogu čuti tiši klik neposredno prije drugog glasnog klika.
Some patients may require higher doses of tacrolimus or cyclosporine A than at the initiation of treatment.
Neki bolesnici mogu zahtijevati više doze takrolimusa ili ciklosporina A nego na početku liječenja.
Some patients may respond very rapidly and with a considerable increase in neutrophil count to the initial dose of filgrastim.
Neki bolesnici mogu vrlo brzo odgovoriti i to znatnim povećanjem broja neutrofila na početnu dozu filgrastima.
Some patients might experience dizziness, somnolence or visual disorders, particularly on initiation of treatment.
Neki pacijenti mogu osjetiti omaglicu, somnolenciju ili poremećaje vida, osobito na početku liječenja.
Some patients need a higher dose and your doctor will work out the dose that is best for you.
Neki bolesnici trebaju višu dozu pa će Vaš liječnik utvrditi koja je doza najbolja za Vas.
Some patients required discontinuation of Torisel or treatment with corticosteroids and/or antibiotics, while some patients continued treatment without additional intervention.
U nekih je bolesnika bilo potrebno prekinuti primjenu Torisela ili uvesti liječenje kortikosteroidima i/ili antibioticima, dok su drugi nastavili liječenje bez dodatne intervencije.
Some patients taking combination antiretroviral medicines such as Emtricitabine /Tenofovir disoproxil Zentiva may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone).
U nekih bolesnika koji uzimaju kombiniranu antiretrovirusnu terapiju kao što je Emtricitabine/Tenofovir disoproxil Zentiva može se razviti koštana bolest koja se naziva osteonekrozom (odumiranje koštanog tkiva uzrokovano gubitkom opskrbe kosti krvlju).
Some patients taking combination antiretroviral medicines such as Truvada may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone).
U nekih se pacijenata koji uzimaju kombiniranu antiretrovirusnu terapiju kao što je Truvada može razviti koštana bolest koja se naziva osteonekrozom (odumiranje koštanog tkiva uzrokovano gubitkom dovoda krvi u kost).
Some patients taking combination antiretroviral therapy may develop a bone disease called osteonecrosis (death of bone tissue caused by loss of blood supply to the bone).
Neki bolesnici koji primaju kombiniranu antiretrovirusnu terapiju mogu razviti bolest kostiju koja se naziva osteonekroza (odumiranje koštanog tkiva uzrokovano prekidom opskrbe kosti krvlju).
Some patients taking Exviera are also treated with another antiviral medicine, ribavirin, in addition to Viekirax.
Neke bolesnike koji uzimaju lijek Exviera također se liječi i drugim protuvirusnim lijekom, ribavirinom, uz terapiju Viekiraxom.
Some patients taking Lyrica have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali lijek Lyrica prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking Norvir can develop serious problems with their pancreas.
U nekih se bolesnika koji uzimaju Norvir mogu javiti ozbiljne poteškoće s gušteračom.
Some patients taking Norvir may experience changes in the electrocardiogram (ECG).
U nekih bolesnika koji uzimaju Norvir mogu se javiti promjene elektrokardiograma (EKG).
Some patients taking pregabalin have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali pregabalin prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking Pregabalin Mylan have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali lijek Pregabalin Mylan prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking Pregabalin Mylan Pharma have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali lijek Pregabalin Mylan Pharma prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking Pregabalin Pfizer have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali lijek Pregabalin Pfizer prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking Pregabalin Sandoz GmbH have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali lijek Pregabalin Sandoz GmbH prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking Pregabalin Sandoz have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali lijek Pregabalin Sandoz prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking sedative-hypnotics have had additional symptoms such as dyspnoea, throat closing, or nausea and vomiting.
U nekih bolesnika koji su uzimali sedative-hipnotike postojali su i dodatni simptomi poput dispneje, stezanja grla ili mučnine i povraćanja.
Some patients taking STAYVEER have been found to have abnormal liver function tests and anaemia (low haemoglobin).
Kod nekih bolesnika koji uzimaju STAYVEER utvrđeni su abnormalni testovi funkcije jetre te anemija (snižena koncentracija hemoglobina).
Some patients taking this medicine have reported symptoms suggesting an allergic reaction.
Neki bolesnici koji su uzimali ovaj lijek prijavili su simptome koji ukazuju na alergijsku reakciju.
Some patients taking Tracleer have been found to have abnormal liver function tests and anaemia (low haemoglobin).
Kod nekih bolesnika koji uzimaju Tracleer utvrđeni su abnormalni testovi funkcije jetre te anemija (snižena koncentracija hemoglobina).
Some patients taking Tracleer were found to have abnormal liver function tests.
Neki bolesnici koji su uzimali Tracleer, imali su promijenjene nalaze jetrene funkcije.
Some patients treated with golimumab have developed certain kinds of skin cancer.
U nekih bolesnika liječenih golimumabom razvile su se određene vrste raka kože.
Some patients treated with infliximab have developed certain kinds of skin cancer.
U nekih bolesnika liječenih infliksimabom razvile su se određene vrste raka kože.
Some patients who developed rash also had:
Neki bolesnici koji su razvili osip također su imali:
Some patients who experience decrease in their response may benefit from an increase in dosing frequency to 40 mg Humira every week.
U nekih bolesnika u kojih dođe do slabljenja odgovora na terapiju možda će biti korisno povećati učestalost doziranja na 40 mg lijeka Humira svaki tjedan.
Some patients who have received TNF-blockers, including Flixabi have developed a rare type of cancer called Hepatosplenic T-cell Lymphoma.
U nekih bolesnika koji su liječeni blokatorima TNF-a uključujući Flixabi razvio se rijedak oblik raka zvan hepatosplenički limfom T-stanica.
Some patients who have received TNF-blockers, including Inflectra have developed a rare type of cancer called Hepatosplenic T-cell Lymphoma.
U nekih bolesnika koji su liječeni TNF-blokatorima, uključujući lijek Inflectru razvio se rijedak oblik raka zvan hepatosplenički limfom T-stanica.
Some patients who have received TNF-blockers, including Remicade have developed a rare type of cancer called Hepatosplenic T-cell Lymphoma.
U nekih bolesnika koji su liječeni TNF-blokatorima uključujući Remicade razvio se rijedak oblik raka zvan hepatosplenički limfom T-stanica.
Some patients who have received TNF-blockers, including Remsima have developed a rare type of cancer called Hepatosplenic T-cell Lymphoma.
U nekih bolesnika koji su liječeni TNF-blokatorima uključujući Remsima razvio se rijedak oblik raka zvan hepatosplenički limfom T-stanica.
Some patients who received Somavert developed anti-growth hormone antibodies (proteins that are produced in response to Somavert), but the clinical importance of this side effect is not known.
Pojedini bolesnici koji su primili lijek Somavert razvili su protutijela na hormon rasta (bjelančevine koji nastaju kao odgovor na lijek Somavert), no klinički značaj ove nuspojave nije poznat.
Some patients who stop taking ARICLAIM suddenly have had symptoms such as: dizziness, tingling feelings like pins and needles or electric shock-like feelings (particularly in the head), sleep disturbances (vivid dreams, nightmares, inability to sleep), fatigue, sleepiness, feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), shaking (tremor), headaches, muscle pain, feeling irritable, diarrhoea, excessive sweating or vertigo.
Neki bolesnici koji su naglo prekinuli uzimati ARICLAIM imali su simptome kao što su: omaglica, osjećaj trnaca poput bockanja i iglica ili osjeti nalik strujnom udaru (osobito u glavi), poremećaji spavanja (živopisni snovi, noćne more, nemogućnost spavanja), umor, pospanost, osjećaj nemira ili uznemirenosti, osjećaj tjeskobe, mučnina ili povraćanje, nevoljno drhtanje (tremor) glavobolja, bol u mišićima, razdražljivost, proljev, prekomjerno znojenje ili vrtoglavica.
Some patients who stop taking Duloxetine Lilly suddenly have had symptoms such as: dizziness, tingling feelings like pins and needles or electric shock-like feelings (particularly in the head), sleep disturbances (vivid dreams, nightmares, inability to sleep), fatigue, sleepiness, feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), shaking (tremor), headaches, muscle pain, feeling irritable, diarrhoea, excessive sweating or vertigo.
U nekih bolesnika koji naglo prestanu uzimati lijek Duloksetin Lilly jave se simptomi kao što su: omaglica, trnci ili osjeti nalik strujnom udaru (osobito u glavi), smetnje spavanja (živopisni snovi, noćne more, nemogućnost spavanja), umor, pospanost, nemir ili uznemirenost, tjeskoba, mučnina ili povraćanje, nevoljno drhtanje (tremor), glavobolja, bol u mišićima, razdražljivost, proljev, prekomjerno znojenje ili vrtoglavica.
Some patients who stop taking Duloxetine Mylan suddenly have had symptoms such as: dizziness, tingling feelings like pins and needles or electric shock like feelings (particularly in the head), sleep disturbances (vivid dreams, nightmares, inability to sleep), fatigue, sleepiness, feeling restless or agitated, feeling anxious, feeling sick (nausea) or being sick (vomiting), shaking (tremor), headaches, muscle pain, feeling irritable, diarrhoea, excessive sweating or vertigo.
U nekih bolesnika koji naglo prestanu uzimati lijek Duloxetine Mylan jave se simptomi kao što su: omaglica, trnci ili osjeti nalik strujnom udaru (osobito u glavi), smetnje spavanja (živopisni snovi, noćne more, nemogućnost spavanja), umor, pospanost, nemir ili uznemirenost, tjeskoba, mučnina ili povraćanje, nevoljno drhtanje (tremor), glavobolja, bol u mišićima, razdražljivost, proljev, prekomjerno znojenje ili vrtoglavica.